Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model

References

• Ahnstedt H, Stenman E, Cao L, et al. (2012). Cytokines and growth factors modify the upregulation of contractile endothelin ET(A) and ET(B) receptors in rat cerebral arteries after organ culture. Acta Physiol 205:266–78.
   PubMed Web of Science ®Google Scholar
• Ansar S, Larsen C, Maddahi A, Edvinsson L. (2010). Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries. Brain Res 1316:163–72.
   PubMed Web of Science ®Google Scholar
• Ansar S, Vikman P, Nielsen M, et al. (2007). 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 293:H3750–H3758.
   PubMed Web of Science ®Google Scholar
• Bain J, Plater L, Elliott M, et al. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297–315.
   PubMed Web of Science ®Google Scholar
• Bardutzky J, Meng X, Bouley J, et al. (2005). Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab 25:968–77.
   PubMed Web of Science ®Google Scholar
• Christensen ST, Johansson SE, Radziwon-Balicka A, et al. (2019). MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats. PLoS One 14:e0215398.
   PubMed Web of Science ®Google Scholar
• Davenport AP, Hyndman KA, Dhaun N, et al. (2016). Endothelin. Pharmacol Rev 68:357–418.
   PubMed Web of Science ®Google Scholar
• Davies SP, Reddy H, Caivano M, Cohen P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105.
   PubMed Web of Science ®Google Scholar
• Duncia JV, Santella JB, III, Higley CA, et al. (1998). MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett 8:2839–44.
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Larsen SS, Maddahi A, Nielsen J. (2014). Plasticity of cerebrovascular smooth muscle cells after subarachnoid hemorrhage. Transl Stroke Res 5:365–76.
   PubMed Web of Science ®Google Scholar
• Edvinsson LI, Povlsen GK. (2011). Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 31:1554–71.
   PubMed Web of Science ®Google Scholar
• Favata MF, Horiuchi KY, Manos EJ, et al. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623–32.
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, Sparreboom A. (2001). Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590–8.
   PubMed Web of Science ®Google Scholar
• Grell AS, Mostajeran M, Frederiksen SD, et al. (2017). Cerebrovascular gene expression in spontaneously hypertensive rats after transient middle cerebral artery occlusion. Neuroscience 367:219–32.
   PubMed Web of Science ®Google Scholar
• Haanes KA, Schwab A, Novak I. (2012). The P2X7 receptor supports both life and death in fibrogenic pancreatic stellate cells. PLoS One 7:e51164.
   PubMed Web of Science ®Google Scholar
• Hansen-Schwartz J, Hoel NL, Xu CB, et al. (2003a). Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in rats. J Neurosurg 99:115–20.
   PubMed Web of Science ®Google Scholar
• Hansen-Schwartz J, Hoel NL, Zhou M, et al. (2003b). Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52:1188–94.
   PubMed Web of Science ®Google Scholar
• Henriksson M, Stenman E, Vikman P, Edvinsson L. (2007). Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat. BMC Neurosci 8:7.
   PubMed Web of Science ®Google Scholar
• Henriksson M, Xu CB, Edvinsson L. (2004). Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol 142:1155–61.
   PubMed Web of Science ®Google Scholar
• Hogestatt ED, Andersson KE, Edvinsson L. (1983). Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49–61.
   PubMedGoogle Scholar
• Kiss L, Walter FR, Bocsik A, et al. (2013). Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci 102:1173–81.
   PubMed Web of Science ®Google Scholar
• Larsen CC, Povlsen GK, Rasmussen MN, Edvinsson L. (2011). Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats. J Neurosurg 114:1143–53.
   PubMed Web of Science ®Google Scholar
• Li J, Cao YX, Liu Y, Xu CB. (2012). Minimally modified LDL upregulates endothelin type B receptors in rat basilar artery. Microvasc Res 83:178–84.
   PubMed Web of Science ®Google Scholar
• Liu B, Gordon WP, Richmond W, et al. (2016). Use of solubilizers in preclinical formulations: effect of Cremophor EL on the pharmacokinetic properties on early discovery compounds. Eur J Pharm Sci 87:52–7.
   PubMed Web of Science ®Google Scholar
• Macdonald RL. (2014). Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10:44–58.
   PubMed Web of Science ®Google Scholar
• Maddahi A, Ansar S, Chen Q, Edvinsson L. (2011). Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J Cereb Blood Flow Metab 31:144–54.
   PubMed Web of Science ®Google Scholar
• Mulvany MJ, Halpern W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41:19–26.
   PubMed Web of Science ®Google Scholar
• O'Collins VE, Macleod MR, Donnan GA, et al. (2006). 1,026 experimental treatments in acute stroke. Ann Neurol 59:467–77.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2011). Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS 8:7.
   PubMedGoogle Scholar
• Povlsen GK, Edvinsson L. (2015). MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats. J Cereb Blood Flow Metab 35:329–37.
   PubMed Web of Science ®Google Scholar
• Povlsen GK, Johansson SE, Larsen CC, et al. (2013). Early events triggering delayed vasoconstrictor receptor upregulation and cerebral ischemia after subarachnoid hemorrhage. BMC Neurosci 14:34.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Simon RP, Graham SH. (1997). Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats. Neurosci Lett 239:125–7.
   PubMed Web of Science ®Google Scholar
• Smith ER, Hadidian Z, Mason MM. (1967). The single-and repeated-dose toxicity of dimethyl sulfoxide. Ann N Y Acad Sci 141:96–109.
   PubMed Web of Science ®Google Scholar
• Spray S, Johansson SE, Radziwon-Balicka A, et al. (2017). Enhanced contractility of intraparenchymal arterioles after global cerebral ischaemia in rat - new insights into the development of delayed cerebral hypoperfusion. Acta Physiol 220:417–31.
   PubMed Web of Science ®Google Scholar
• Spray S, Rasmussen MN, Skovsted GF, et al. (2016). Reduced mechanical stretch induces enhanced endothelin B receptor-mediated contractility via activation of focal adhesion kinase and extracellular regulated kinase 1/2 in cerebral arteries from rat. Basic Clin Pharmacol Toxicol 119:68–77.
   PubMed Web of Science ®Google Scholar
• Tiemann C, Prohaska W, Korfer R, et al. (1997). Effect of cyclosporine A on the release of tissue factor pathway inhibitor from endothelial cells in heart transplant patients and cell culture. Eur J Clin Chem Clin Biochem 35:661–7.
   PubMedGoogle Scholar
• Uitdehaag JC, Verkaar F, Alwan H, et al. (2012). A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets. Br J Pharmacol 166:858–76.
   PubMed Web of Science ®Google Scholar
• Vikman P, Edvinsson L. (2006). Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol 13:1324–32.
   PubMed Web of Science ®Google Scholar
• Warlow C, Sudlow C, Dennis M, et al. (2003). Stroke. Lancet 362:1211–24.
   PubMed Web of Science ®Google Scholar
• Weaver ML, Grossi AB, Schutzsack J, et al. (2016). Vehicle systems and excipients used in minipig drug development studies. Toxicol Pathol 44:367–72.
   PubMed Web of Science ®Google Scholar
• Wityak J, Hobbs FW, Gardner DS, et al. (2004). Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors. Bioorg Med Chem Lett 14:1483–6.
   PubMed Web of Science ®Google Scholar
• Zhao FK, Chuang LF, Israel M, Chuang RY. (1989). Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C. Biochem Biophys Res Commun 159:1359–67.
   PubMed Web of Science ®Google Scholar